LSECs have been described to prime tolerance through CD8+ T presentation in low antigenic concentration [32,33] and even to activate CD4+ T cells to become regulatory and, therefore, protective while suppressing inflammatory CD4+ T cells in a model of T cell-mediated hepatitis [34,35]. This evidence concerns the gene CD8A and hepatitis A virus infection.